Oral microbiota analyses of Saudi sickle cell anemics with dental caries (vol 73, pg 144, 2023)

被引：0

作者：

Alyousef, Yousef M. ^{[1
]}

Alonaizan, Faisal A. ^{[1
]}

Alsulaiman, Ahmed A. ^{[1
]}

Abukabbos, Halima ^{[2
]}

Aldarwish, Mohammed I. ^{[3
]}

Alali, Ali A. ^{[1
]}

Almasood, Naif N. ^{[1
]}

Vatte, Chittibabu ^{[4
]}

Cyrus, Cyril ^{[4
]}

Habara, Alawi H. ^{[4
]}

Koeleman, Bobby P. C. ^{[5
]}

机构：

[1] Imam Abdulrahman bin Faisal Univ, Coll Dent, Dammam, Saudi Arabia

[2] Univ Detroit Mercy, Sch Dent, Dept Pediat Dent, Michigan, ND USA

[3] Qatif Cent Hosp, Qatif, Saudi Arabia

[4] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Clin Biochem, Dammam, Saudi Arabia

[5] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands

来源：

INTERNATIONAL DENTAL JOURNAL | 2023年 / 73卷 / 03期

关键词：

D O I：

10.1016/j.identj.2023.03.013

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

引用

页码：470 / 470

页数：1

共 27 条

[21] Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation (vol 228, pg 627, 2023)
Margolis, E. B.
Maron, G.
Sun, Y.
JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (04): : 1246 - 1246
[22] Primary prevention of sickle cell disease using preimplantation genetic testing and in vitro fertilization is cost-effective (Withdrawal of Vol 98, Pg 1819, 2020) (Withdrawn Publication. See AUG, 2023)
Mitchell, Christina N. Cordeiro
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : 1819 - 1819
[23] Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 (vol 10, pg e585, 2023)
Gurnari, C.
Spadea, M.
Muratori, R.
LANCET HAEMATOLOGY, 2023, 10 (08): : E574 - E574
[24] RETRACTED: ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma (Retracted article. See vol. 15, pg. 787, 2023)
Wang, Xiaolon
Hao, Rui
Wang, Fengjuan
Wang, Fan
CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7251 - 7262
[25] Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy (vol 118, pg 404, 2023)
Simone II, C. B.
Serebrenik, A. A.
Gore, E. M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (03): : 1029 - 1029
[26] Association of immune-related adverse events with efficacy of atezolizumab in patients with non-small cell lung cancer: pooled analyses of the phase 3 IMpower130, IMpower132, and IMpower150 randomized clinical trials (vol 9, pg 527, 2023)
Walls, Gerard M.
Hanna, Gerard G.
JAMA ONCOLOGY, 2023, 9 (04) : 574 - 574
[27] RETRACTED: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131 (Retracted article. See vol. 75, pg. 142, 2023)
Velu, Periyannan
Vijayalakshmi, Annamalai
Vinothkumar, Veerasamy
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (11) : 1595 - 1606

← 1 2 3 →